Prevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV-infected women in Botswana

Journal of Medical Virology

Volumn 83, Issue 10, 2011, Pages 1689-1695

  Macleod, Iain J ^a,b   O'Donnell, Belinda ^b   Moyo, Sikhulile ^b   Lockman, Shahin ^a,b,c   Shapiro, Roger L ^a,b,d   Kayembe, Mukendi ^e   van Widenfelt, Erik ^b   Makhema, Joseph ^a,b   Essex, M ^a,b   Wester, Carolyn ^a,b  

^a Harvard AIDS Institute   (United States)

^b BOTSWANA HARVARD AIDS INSTITUTE PARTNERSHIP   (Botswana)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e National Health Laboratory   (Botswana)

Author keywords

Cervical cancer; Co infection; HIV; Human papillomavirus

Indexed keywords

ADULT; ARTICLE; BOTSWANA; COHORT ANALYSIS; CYTOLOGY; DISEASE ASSOCIATION; DNA EXTRACTION; FEMALE; GENOTYPE; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PREVALENCE; SEROLOGY; UTERINE CERVIX DISEASE; UTERINE CERVIX EPITHELIUM; VIRUS SHEDDING; WART VIRUS;

ADULT; ALPHAPAPILLOMAVIRUS; BOTSWANA; CAPSID PROTEINS; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; DNA, VIRAL; FEMALE; GENOTYPE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; PAPILLOMAVIRUS INFECTIONS;

HUMAN HERPESVIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 80051594337     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22178     Document Type: Article

References (27)

1. Auvert B, Lissouba P, Cutler E, Zarca K, Puren A, Taljaard D. 2010. Association of oncogenic and nononcogenic human papillomavirus with HIV incidence. J Acquir Immune Defic Syndr 53: 111-116.
2. Averbach SH, Gravitt PE, Nowak RG, Celentano DD, Dunbar MS, Morrison CS, Grimes B, Padian NS. 2010. The association between cervical human papillomavirus infection and HIV acquisition among women in Zimbabwe. AIDS 24: 1035-1042.
3. Banura C, Franceschi S, Doorn LJ, Arslan A, Wabwire-Mangen F, Mbidde EK, Quint W, Weiderpass E. 2008. Infection with human papillomavirus and HIV among young women in Kampala, Uganda. J Infect Dis 197: 555-562.
4. Banura C, Sandin S, van Doorn LJ, Quint W, Kleter B, Wabwire-Mangen F, Mbidde EK, Weiderpass E. 2010. Type-specific incidence, clearance and predictors of cervical human papillomavirus infections (HPV) among young women: A prospective study in Uganda. Infect Agent Cancer 5: 7.
5. Coleman N, Birley HD, Renton AM, Hanna NF, Ryait BK, Byrne M, Taylor-Robinson D, Stanley MA. 1994. Immunological events in regressing genital warts. Am J Clin Pathol 102: 768-774.
6. Dames DN, Ragin C, Griffith-Bowe A, Gomez P, Butler R. 2009. The prevalence of cervical cytology abnormalities and human papillomavirus in women infected with the human immunodeficiency virus. Infect Agent Cancer 4: S8.
7. del Amo J, Gonzalez C, Losana J, Clavo P, Munoz L, Ballesteros J, Garcia-Saiz A, Belza MJ, Ortiz M, Menendez B, del Romero J, Bolumar F. 2005. Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain. Sex Transm Infect 81: 79-84.
8. Firnhaber C, Van Le H, Pettifor A, Schulze D, Michelow P, Sanne IM, Lewis DA, Williamson AL, Allan B, Williams S, Rinas A, Levin S, Smith JS. 2010. Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes Control 21: 433-443.
9. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. 2010. Human papillomavirus type distribution in 30, 848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer 128: 927-935.
10. Luchters SM, Vanden Broeck D, Chersich MF, Nel A, Delva W, Mandaliya K, Depuydt CE, Claeys P, Bogers JP, Temmerman M. 2010. Association of HIV infection with distribution and viral load of HPV types in Kenya: A survey with 820 female sex workers. BMC Infect Dis 10: 18.
11. Luque AE, Jabeen M, Messing S, Lane CA, Demeter LM, Rose RC, Reichman RC. 2006. Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York. J Infect Dis 194: 428-434.
12. Moodley JR, Constant D, Hoffman M, Salimo A, Allan B, Rybicki E, Hitzeroth I, Williamson AL. 2009. Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: A cross-sectional study. BMC Cancer 9: 275.
13. Munoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV, Meijer CJ, Bosch FX. 2002. Role of parity and human papillomavirus in cervical cancer: The IARC multicentric case-control study. Lancet 359: 1093-1101.
14. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527.
15. NACA. 2008. Botswana AIDS Impact Survey III: Statistical Report. Gaborone: National AIDS Coordinating Agency.
16. Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick J, Jaisamrarn U, Limson G, Garland S, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Jenkins D, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G, Greenacre M. 2009. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women. Lancet 374: 301-314.
17. Romanowski B. 2010. Efficacy of the HPV-16/18 adjuvanted vaccine against non-vaccine oncogenic HPV types: End-of-study results. 26th International Papillomavirus Congress (IPC). Montreal, Canada.
18. Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, Huh WK, Lyon MD, Stringer JS, Parham GP. 2007. Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Br J Cancer 96: 1480-1483.
19. Schiffman M, Clifford G, Buonaguro FM. 2009. Classification of weakly carcinogenic human papillomavirus types: Addressing the limits of epidemiology at the borderline. Infect Agent Cancer 4: 8.
20. Schuman P, Ohmit SE, Klein RS, Duerr A, Cu-Uvin S, Jamieson DJ, Anderson J, Shah KV. 2003. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis 188: 128-136.
21. Smith JS, Moses S, Hudgens MG, Parker CB, Agot K, Maclean I, Ndinya-Achola JO, Snijders PJ, Meijer CJ, Bailey RC. 2010. Increased risk of HIV acquisition among Kenyan men with human papillomavirus infection. J Infect Dis 201: 1677-1685.
22. Smith-McCune KK, Shiboski S, Chirenje MZ, Magure T, Tuveson J, Ma Y, Da Costa M, Moscicki AB, Palefsky JM, Makunike-Mutasa R, Chipato T, van der Straten A, Sawaya GF. 2010. Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PLoS ONE 5: e10094.
23. Stanley M. 2008. Immunobiology of HPV and HPV vaccines. Gynecol Oncol 109: S15-S21.
24. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, Hall C, Bacon M, Levine AM, Watts DH, Silverberg MJ, Xue X, Schlecht NF, Melnick S, Palefsky JM. 2005. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 97: 577-586.
25. Veldhuijzen NJ, Vyankandondera J, van de Wijgert JH. 2010. HIV acquisition is associated with prior high-risk human papillomavirus infection among high-risk women in Rwanda. AIDS 24: 2289-2292.
26. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in Botswana. Summary Report 2010. Available at .
27. Woo YL, Damay I, Stanley M, Crawford R, Sterling J. 2007. The use of HPV Linear Array Assay for multiple HPV typing on archival frozen tissue and DNA specimens. J Virol Methods 142: 226-230.